Frighetto Luciana, Marra Carlo, Bandali Shakeel, Wilbur Kerry, Naumann Terryn, Jewesson Peter
Pharmaceutical Sciences Clinical Service Unit, Vancouver Hospital and Health Sciences Center, 855 West 12th Avenue, Vancouver, BC, Canada.
Health Qual Life Outcomes. 2004 Mar 24;2:17. doi: 10.1186/1477-7525-2-17.
Hospitalization can significantly disrupt sleeping patterns. In consideration of the previous reports of insomnia and apparent widespread use of benzodiazepines and other hypnotics in hospitalized patients, we conducted a study to assess quality of sleep and hypnotic drug use in our acute care adult patient population. The primary objectives of this study were to assess sleep disturbance and its determinants including the use of drugs with sedating properties.
This single-centre prospective study involved an assessment of sleep quality for consenting patients admitted to the general medicine and family practice units of an acute care Canadian hospital. A validated Verran and Snyder-Halpern (VSH) Sleep Scale measuring sleep disturbance, sleep effectiveness, and sleep supplementation was completed daily by patients and scores were compared to population statistics. Patients were also asked to identify factors influencing sleep while in hospital, and sedating drug use prior to and during hospitalization was also assessed.
During the 70-day study period, 100 patients completed at least one sleep questionnaire. There was a relatively even distribution of males versus females, most patients were in their 8th decade of life, retired, and suffered from multiple chronic diseases. The median self-reported pre-admission sleep duration for participants was 8 hours and our review of PharmaNet profiles revealed that 35 (35%) patients had received a dispensed prescription for a hypnotic or antidepressant drug in the 3-month period prior to admission. Benzodiazepines were the most common sedating drugs prescribed. Over 300 sleep disturbance, effective and supplementation scores were completed. Sleep disturbance scores across all study days ranged 16-681, sleep effectiveness scores ranged 54-402, while sleep supplementation scores ranged between 0-358. Patients tended to have worse sleep scores as compared to healthy non-hospitalized US adults in all three scales. When compared to US non-hospitalized adults with insomnia, our patients demonstrated sleep disturbance and supplementation scores that were similar on Day 1, but lower (i.e. improved) on Day 3, while sleep effectiveness were higher (i.e. better) on both days. There was an association between sleep disturbance scores and the number of chronic diseases, the presence of pain, the use of bedtime tricyclic antidepressants, and the number of chronic diseases without pain. There was also an association between sleep effectiveness scores and the length of hospitalization, the in hospital use of bedtime sedatives and the presence of pain. Finally, an association was identified between sleep supplementation scores and the in hospital use of bedtime sedatives (tricyclic antidepressants and loxapine), and age. Twenty-nine (29%) patients received a prescription for a hypnotic drug while in hospital, with no evidence of pre-admission hypnotic use. The majority of these patients were prescribed zopiclone, lorazepam or another benzodiazepine.
The results of this study reveal that quality of sleep is a problem that affects hospitalized adult medical service patients and a relatively high percentage of these patients are being prescribed a hypnotic prior to and during hospitalization.
住院会严重扰乱睡眠模式。鉴于此前有关于住院患者失眠以及苯二氮䓬类药物和其他催眠药广泛使用的报道,我们开展了一项研究,以评估成年急症患者的睡眠质量和催眠药物使用情况。本研究的主要目的是评估睡眠障碍及其决定因素,包括具有镇静作用药物的使用情况。
这项单中心前瞻性研究对加拿大一家急症医院普通内科和家庭医疗科收治的同意参与研究的患者的睡眠质量进行了评估。患者每天填写一份经过验证的Verran和Snyder-Halpern(VSH)睡眠量表,该量表用于测量睡眠障碍、睡眠效果和睡眠补充情况,并将得分与总体统计数据进行比较。患者还被要求指出住院期间影响睡眠的因素,同时评估住院前和住院期间镇静药物的使用情况。
在为期70天的研究期间,100名患者至少完成了一份睡眠问卷。男女分布相对均匀,大多数患者为80多岁,已退休,患有多种慢性疾病。参与者入院前自我报告的睡眠时间中位数为8小时,我们对PharmaNet档案的审查显示,35名(35%)患者在入院前3个月内收到过催眠药或抗抑郁药的处方。苯二氮䓬类药物是最常用的镇静药物。共完成了300多项睡眠障碍、睡眠效果和睡眠补充得分。所有研究日的睡眠障碍得分在16 - 681之间,睡眠效果得分在54 - 402之间,而睡眠补充得分在0 - 358之间。与健康的非住院美国成年人相比,患者在所有三个量表上的睡眠得分往往更差。与患有失眠的非住院美国成年人相比,我们的患者在第1天的睡眠障碍和睡眠补充得分相似,但在第3天更低(即有所改善),而在这两天的睡眠效果得分更高(即更好)。睡眠障碍得分与慢性疾病数量、疼痛的存在、睡前使用三环类抗抑郁药以及无痛慢性疾病的数量之间存在关联。睡眠效果得分与住院时间、住院期间睡前使用镇静剂以及疼痛的存在之间也存在关联。最后,睡眠补充得分与住院期间睡前使用镇静剂(三环类抗抑郁药和洛沙平)以及年龄之间存在关联。29名(29%)患者在住院期间收到了催眠药处方,且没有入院前使用催眠药的证据。这些患者大多数被开了佐匹克隆、劳拉西泮或其他苯二氮䓬类药物。
本研究结果表明,睡眠质量是影响成年住院内科患者的一个问题,这些患者中有较高比例在住院前和住院期间被开了催眠药。